Restasis is a brand-name eye drop that’s prescribed for chronic dry eye. The medication is available in single-use and multiuse vials. Restasis is a type of immunosuppressant. Restasis is approved by ...

Restasis (cyclosporine ophthalmic emulsion) is a prescription drug that’s used to treat dry eye syndrome. The drug comes as an emulsion (oily liquid). You usually apply 1 drop into each affected eye ...

If you have chronic (long-term) dry eye, your doctor might suggest treatment with Xiidra or Restasis. They’re both prescription medications prescribed to treat chronic dry eye (also called dry eye ...

Restasis, a calcineurin inhibitor immunosuppressant, helps increase the eyes' natural ability to produce tears in patients whose tear production is presumed to be suppressed due to ocular inflammation ...

Please provide your email address to receive an email when new articles are posted on . For the past 2 years I have jokingly labeled this month’s column my annual lifitegrast edition. Now that Xiidra ...

It’s not exactly going to be smooth sailing for Allergan’s multidose bottle version of dry-eye med Restasis. As it finally gets the green light from the FDA, a new challenge named Xiidra lies ahead.

Restasis, a calcineurin inhibitor immunosuppressant, is indicated to increase tear production. The Food and Drug Administration (FDA) has approved Restasis MultiDose (cyclosporine ophthalmic emulsion ...

MARKHAM, ON, June 7, 2018 /CNW/ - Allergan plc announced today that it has received approval from Health Canada for RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05%. RESTASIS MULTIDOSE™ is ...

-- New Delivery System Will Now Provide RESTASIS ® in a Preservative Free, Easy-to-Use, Multi-Dose Bottle-- -- RESTASIS the Only* Health Canada Approved Treatment to Help Patients Produce More of ...